Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5–15% and PGA ≥ 3: Post-Hoc Analysis From Three Randomized Controlled Trials

INTRODUCTION: Psoriasis is a chronic, inflammatory disease, which ranges in severity from mild to severe. Although topical therapies are frequently used to treat mild disease, they are not routinely used to treat patients with moderate-to-severe disease who have a larger proportion of their body sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Iversen, Lars, Kurvits, Merle, Snel-Prentø, Anja Marieke, Menter, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477061/
https://www.ncbi.nlm.nih.gov/pubmed/32785881
http://dx.doi.org/10.1007/s13555-020-00419-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477061/
https://www.ncbi.nlm.nih.gov/pubmed/32785881
http://dx.doi.org/10.1007/s13555-020-00419-2

Ejemplares similares